Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study.
COLD-CE
adrenaline autoinjector
cold urticaria
risk factors
systemic reactions
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
11
11
2021
received:
12
10
2021
accepted:
20
11
2021
pubmed:
5
12
2021
medline:
2
7
2022
entrez:
4
12
2021
Statut:
ppublish
Résumé
Cold urticaria (ColdU), that is, the occurrence of wheals or angioedema in response to cold exposure, is classified into typical and atypical forms. The diagnosis of typical ColdU relies on whealing in response to local cold stimulation testing (CST). It can also manifest with cold-induced anaphylaxis (ColdA). We aimed to determine risk factors for ColdA in typical ColdU. An international, cross-sectional study COLD-CE was carried out at 32 urticaria centers of reference and excellence (UCAREs). Detailed history was taken and CST with an ice cube and/or TempTest Of 551 ColdU patients, 75% (n = 412) had a positive CST and ColdA occurred in 37% (n = 151) of the latter. Cold-induced generalized wheals, angioedema, acral swelling, oropharyngeal/laryngeal symptoms, and itch of earlobes were identified as signs/symptoms of severe disease. ColdA was most commonly provoked by complete cold water immersion and ColdA caused by cold air was more common in countries with a warmer climate. Ten percent (n = 40) of typical ColdU patients had a concomitant chronic spontaneous urticaria (CSU). They had a lower frequency of ColdA than those without CSU (4% vs. 39%, p = .003). We identified the following risk factors for cardiovascular manifestations: previous systemic reaction to a Hymenoptera sting, angioedema, oropharyngeal/laryngeal symptoms, and itchy earlobes. ColdA is common in typical ColdU. High-risk patients require education about their condition and how to use an adrenaline autoinjector.
Sections du résumé
BACKGROUND
Cold urticaria (ColdU), that is, the occurrence of wheals or angioedema in response to cold exposure, is classified into typical and atypical forms. The diagnosis of typical ColdU relies on whealing in response to local cold stimulation testing (CST). It can also manifest with cold-induced anaphylaxis (ColdA). We aimed to determine risk factors for ColdA in typical ColdU.
METHODS
An international, cross-sectional study COLD-CE was carried out at 32 urticaria centers of reference and excellence (UCAREs). Detailed history was taken and CST with an ice cube and/or TempTest
RESULTS
Of 551 ColdU patients, 75% (n = 412) had a positive CST and ColdA occurred in 37% (n = 151) of the latter. Cold-induced generalized wheals, angioedema, acral swelling, oropharyngeal/laryngeal symptoms, and itch of earlobes were identified as signs/symptoms of severe disease. ColdA was most commonly provoked by complete cold water immersion and ColdA caused by cold air was more common in countries with a warmer climate. Ten percent (n = 40) of typical ColdU patients had a concomitant chronic spontaneous urticaria (CSU). They had a lower frequency of ColdA than those without CSU (4% vs. 39%, p = .003). We identified the following risk factors for cardiovascular manifestations: previous systemic reaction to a Hymenoptera sting, angioedema, oropharyngeal/laryngeal symptoms, and itchy earlobes.
CONCLUSION
ColdA is common in typical ColdU. High-risk patients require education about their condition and how to use an adrenaline autoinjector.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2185-2199Informations de copyright
© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Maltseva N, Borzova E, Fomina D, et al. Cold urticaria - what we know and what we do not know. Allergy. 2021;76(4):1077-1094.
Bizjak M, Kosnik M, Terhorst-Molawi D, Dinevski D, Maurer M. Cold agglutinins and cryoglobulins associate with clinical and laboratory parameters of cold urticaria. Front Immunol. 2021;12:665491.
Bizjak M, Maurer M, Košnik MTerhorst-Molawi DZver SBurmeister TSiebenhaar F. Severe cold urticaria can point to an underlying clonal mast cell disorder. Allergy. 2021 Aug; 76(8):2609-2613. doi:10.1111/all.14844. Epub 2021 May 5. PMID: 33797762.
Magerl M, Altrichter S, Borzova E, et al. The definition, diagnostic testing, and management of chronic inducible urticarias - the EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy. 2016;71(6):780-802.
Siebenhaar F, Staubach P, Metz M, Magerl M, Jung J, Maurer M. Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol. 2004;114(5):1224-1225.
Magerl M, Abajian M, Krause K, Altrichter S, Siebenhaar F, Church MK. An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria. J Eur Acad Dermatol Venereol. 2015;29(10):2043-2045.
Metz M, Scholz E, Ferran M, Izquierdo I, Gimenez-Arnau A, Maurer M. Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria. Ann Allergy Asthma Immunol. 2010;104(1):86-92.
Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045.
Željko T, Sinkovič A. Anaphylactic shock after Ranitidine - a case report. Acta Medico-Biotechnica. 2010;3(1):51-55. Online access to the journal: http://actamedbio.mf.um.si/sl; Online access to this cited manuscript: http://actamedbio.mf.um.si/revija/article/Anafilakti%C4%8Dni+%C5%A1ok+po+Ranitidinu+%E2%80%93+poro%C4%8Dilo+o+primeru_342
Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082-1123.
Ewan P, Brathwaite N, Leech S, et al. BSACI guideline: prescribing an adrenaline auto-injector. Clin Exp Allergy. 2016;46(10):1258-1280.
Ring J, Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol. 1999;17(4):387-399.
Ginter K, Ahsan DM, Bizjak M, et al. Cryoglobulins, cryofibrinogens, and cold agglutinins in cold urticaria: literature review, retrospective patient analysis, and observational study in 49 patients. Front Immunol. 2021;12:675451. https://doi.org/10.3389/fimmu.2021.675451
Jain SV, Mullins RJ. Cold urticaria: a 20-year follow-up study. J Eur Acad Dermatol Venereol. 2016;30(12):2066-2071.
Fernando SL. Cold-induced anaphylaxis. J Pediatr. 2009;154(1):148.
Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380-384.
Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000;30(8):1144-1150.
Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol. 2007;119(4):1016-1018.
Paulino M, Costa C, Neto M, Pedro E. Cold urticaria. Characterizing the population from an urticaria outpatient clinic. Actas Dermosifiliogr (Engl Ed). 2021;112(8):740-746.
Kulthanan K, Tuchinda P, Chularojanamontri L, Kiratiwongwan R. Cold urticaria: clinical features and natural course in a tropical country. Allergy Asthma Immunol Res. 2019;11(4):538-547.
Yee CSK, El Khoury K, Albuhairi S, Broyles A, Schneider L, Rachid R. Acquired cold-induced urticaria in pediatric patients: a 22-year experience in a tertiary care center (1996-2017). J Allergy Clin Immunol Pract. 2019;7(3):1024-1031 e1023.
Stepaniuk P, Vostretsova K, Kanani A. Review of cold-induced urticaria characteristics, diagnosis and management in a Western Canadian allergy practice. Allergy Asthma Clin Immunol. 2018;14:85.
Deza G, Brasileiro A, Bertolin-Colilla M, Curto-Barredo L, Pujol RM, Gimenez-Arnau AM. Acquired cold urticaria: clinical features, particular phenotypes, and disease course in a tertiary care center cohort. J Am Acad Dermatol. 2016;75(5):918-924 e912.
Siebenhaar F, Degener F, Zuberbier T, Martus P, Maurer M. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123(3):672-679.
Katsarou-Katsari A, Makris M, Lagogianni E, Gregoriou S, Theoharides T, Kalogeromitros D. Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol. 2008;22(12):1405-1411.
Alangari AA, Twarog FJ, Shih MC, Schneider LC. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004;113(4):e313-e317.
Mathelier-Fusade P, Aissaoui M, Bakhos D, Chabane MH, Leynadier F. Clinical predictive factors of severity in cold urticaria. Arch Dermatol. 1998;134(1):106-107.
Wanderer AA, Grandel KE, Wasserman SI, Farr RS. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol. 1986;78(3):417-423.
Doeglas HM, Rijnten WJ, Schroder FP, Schirm J. Cold urticaria and virus infections: a clinical and serological study in 39 patients. Br J Dermatol. 1986;114(3):311-318.
Neittaanmaki H. Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol. 1985;13(4):636-644.
Gernez Y, Sicherer SH, Wang J. Variability in diagnosis and management of acquired cold-induced urticaria. J Allergy Clin Immunol Pract. 2018;6(4):1396-1399.
Maurer M, Metz M, Bindslev-Jensen C, et al. Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and Excellence. Allergy. 2016;71(8):1210-1218.
Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-397.https://pubmed.ncbi.nlm.nih.gov/16461139/
Mlynek A, Magerl M, Siebenhaar F, et al. Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol. 2010;162(1):198-200.
Abajian M, Młynek A, Maurer M. Physical Urticaria. Curr Allergy Asthma Rep. 2012;12(4):281-287.
Buss YL, Sticherling M. Cold urticaria; disease course and outcome-an investigation of 85 patients before and after therapy. Br J Dermatol. 2005;153(2):440-441.
Black AK, Sibbald RG, Greaves MW. Cold urticaria treated by induction of tolerance. Lancet. 1979;2(8149):964.
Hochstadter EF, Ben-Shoshan M. Cold-induced urticaria: challenges in diagnosis and management. BMJ Case Rep. 2013;2013:bcr2013010441.
Krause K, Zuberbier T, Maurer M. Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr Allergy Asthma Rep. 2010;10(4):243-249.
Abajian M, Curto-Barredo L, Krause K, et al. Rupatadine 20 mg and 40 mg are effective in reducing the symptoms of chronic cold urticaria. Acta Derm Venereol. 2016;96(1):56-59.
Kingery FA. Cold Urticaria. JAMA. 1965;192:107.
Stoevesandt J, Sturm GJ, Bonadonna P, Oude Elberink JNG, Trautmann A. Risk factors and indicators of severe systemic insect sting reactions. Allergy. 2020;75(3):535-545.
Kosnik M, Korosec P. Venom immunotherapy: clinical efficacy, safety and contraindications. Expert Rev Clin Immunol. 2015;11(8):877-884.
Selb J, Rijavec M, Erzen R, et al. D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone. J Allergy Clin Immunol. 2021;148(2):621-626 e627. https://pubmed.ncbi.nlm.nih.gov/33753098/
Moller A, Henning M, Zuberbier T, Czarnetzki-Henz BM. Epidemiologie und Klinik der Kälteurtikaria [Epidemiology and clinical aspects of cold urticaria]. Hautarzt. 1996;47(7):510-514. https://pubmed.ncbi.nlm.nih.gov/8926165/